Загрузка...
Advances in targeted therapy for acute myeloid leukemia
Acute myeloid leukemia (AML) is a clonal malignancy characterized by genetic heterogeneity due to recurrent gene mutations. Treatment with cytotoxic chemotherapy has been the standard of care for more than half of a century. Although much progress has been made toward improving treatment related mor...
Сохранить в:
| Опубликовано в: : | Biomark Res |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7238648/ https://ncbi.nlm.nih.gov/pubmed/32477567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-020-00196-2 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|